{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:30:43Z","timestamp":1786728643931,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pediatric pneumonia is a significant cause of inpatient care in the United States. Significant resource utilization and the high cost of care necessitate careful evaluation, especially with continuously decreasing financial resources. Several studies have evaluated subsets and regional impact of these diagnoses, but only a few have evaluated these on a national level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective analysis utilized the 2009\u20132012 HCUP KID Inpatient Dataset to evaluate the relationship between pneumonia diagnosis and factors affecting cost for patients between 0 and 21. One hundred forty-five thousand one hundred forty-six patients' charges with primary pneumonia diagnosis were evaluated based on LOS, chronic conditions, severity, mortality and region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Majority of cases of diagnosis were of unspecified organism: 11,4811 (78%) of the total population. RSV-related pneumonia diagnosis presented second with a total of 8,156 (5.5%). Charges for pneumonia in the Emergency Department (ER) were about $13,104 and non-ER presentation at $10,238. LOS affected total charge and mortality risk for all patient population regardless of age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This nationwide study provides a unique preview of the cost associated with care for pediatric pneumonia. Such information is essential in developing strategies to improve health outcomes and resources allocation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijpam.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T12:22:14Z","timestamp":1556108534000},"page":"79-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pediatric pneumonia"],"prefix":"10.4103","volume":"6","author":[{"given":"Saanie","family":"Sulley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Memory","family":"Ndanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-1-20240319","first-page":"703","article-title":"A practical guide for the diagnosis and treatment ofpediatric pneumonia","volume":"156","author":"Jadavji","year":"1997","journal-title":"CMAJ (Can Med Assoc J): Can Med AssocJ"},{"key":"R4-1-20240319","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/650573","article-title":"Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States","volume":"50","author":"Grijalva","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R5-1-20240319","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1542\/peds.2009-3109","article-title":"National hospitalization trends for pediatric pneumonia and associated complications","volume":"126","author":"Lee","year":"2010","journal-title":"Pediatrics"},{"key":"R6-1-20240319","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(13)60648-0","article-title":"Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost?","volume":"381","author":"Bhutta","year":"2013","journal-title":"Lancet"},{"key":"R7-1-20240319","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/hpeds.2015-0007","article-title":"Hospitalization for community-acquired pneumonia in children: effect of an asthma codiagnosis","volume":"5","author":"Wilson","year":"2015","journal-title":"Hosp Pediatr"},{"key":"R9-1-20240319","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1542\/peds.2009-0184","article-title":"Emphysema hospitalization increased in U.S children despite pneumococal conjucate vaccine","volume":"125","author":"Li","year":"2010","journal-title":"Pediatrics"},{"key":"R11-1-20240319","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40258-013-0026-0","article-title":"Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged\u2265 50 years","volume":"11","author":"Sato","year":"2013","journal-title":"Appl Health Econ Health Policy"}],"updated-by":[{"DOI":"10.1016\/j.ijpam.2020.10.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["International Journal of Pediatrics and Adolescent Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352646719300274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352646719300274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.ijpam.2019.04.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:29:44Z","timestamp":1786724984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.ijpam.2019.04.002"}},"subtitle":["An analysis of cost &amp; outcome influencers in the United States"],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijpam.2019.04.002","relation":{},"ISSN":["2352-6467"],"issn-type":[{"value":"2352-6467","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric pneumonia: An analysis of cost & outcome influencers in the United States","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pediatrics and Adolescent Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpam.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Publishing services provided by Elsevier B.V. on behalf of King Faisal Specialist Hospital & Research Centre (General Organization), Saudi Arabia.","name":"copyright","label":"Copyright"}]}}